Legal and Medical Considerations in the Recommendation of Medical Marijuana

Note: This course is included in the Marij-thon™: Comprehensive Medical Marijuana Course.

Legal and Medical Considerations in the Recommendation of Medical Marijuana provides a thorough review of the considerations associated with the recommendation of medical marijuana including information on the prescribing of FDA-approved cannabinoid-based medicines.

$150.00

Bulk pricing is available! Click here to learn more.

Overview

This course provides a thorough review of the legal and medical considerations associated with the recommendation of medical marijuana. The course is comprised of 3 lessons:

  • Lesson 1: The Laws, The Rules and The Regulations

Lesson 1 discusses the legal issues impacting the production, distribution and use of medical marijuana.  Specifically, this lesson describes the statutes, judicial decisions, and administrative efforts which have shaped the federal posture and influenced the ability of individual states to enact medical marijuana programs.

  • Lesson 2: Recommending Medical Marijuana

Lesson 2 begins with a discussion of the Federation of State Medical Boards’ “Model Guidelines for the Recommendation of Marijuana in Patient Care” and then transitions into a discussion about the medical literature on the health effects of marijuana use.  Specifically, the National Academies of Science, Engineering and Medicine’s 2017 publication, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research will be described in detail.  Lesson 2 also addresses interpreting the results of studies that examine the effects of marijuana use.

  • Lesson 3: The FDA Drug Approval Process and FDA-approved Cannabinoid-based Medicines

Lesson 3 reviews the United States Food and Drug Administration’s (FDA) drug approval process, and provides a description of cannabinoid-based medications that have been approved by the FDA.

Subscribers can complete this CME/CE activity and refer back to the content at any point during their 12-month subscription period.

Content provides Accreditation Council for Continuing Medical Education (ACCME),  Accreditation Council for Pharmacy Education (ACPE), American Association of Nurse Practitioners (AANP), American Nurses Credentialing Center (ANCC), and American Psychological Association (APA) credits.

I don’t plan on recommending marijuana…why would I take this course?

Whether or not you have any intention of recommending medical marijuana for patient care, you need to be well educated in this clinical area because your patients will be seeking your expert advice and guidance for this medication. Further, some of your patients may already be utilizing medical marijuana and you will need to be aware of its physiologic effects as well as its  potential drug interactions. As such, expertise in the endocannabinoid system and medical marijuana is paramount for most doctors, pharmacists, nurses, psychologists, and other allied health professionals to remain that respected guide for their patients’ overall healthcare.

Editorial Team

Editor-in-Chief:
Meredith Fisher-Corn, MD

Founding Editor-in-Chief:
Stephen B. Corn, MD

CME-Certified Activity

Target Audience

The educational design of this activity addresses the needs of all healthcare professionals, but especially ones that practice in a state with a medical marijuana and/or recreational marijuana program.

CME Certification

Content provides Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Association of Nurse Practitioners (AANP), American Nurses Credentialing Center (ANCC), and American Psychological Association (APA) credits.

This curriculum offers up to 1.5 hours of ACCME, ANCC, ACPE, AANP, and APA credit. Full accreditation information is available upon purchase.

Educational Objectives

After completing this activity, the participant should be better able to:

• Discuss the Controlled Substances Act’s scheduling system

• Discuss federal court cases involving the production, distribution and/or recommending of medical marijuana

• Discuss the Cole Memorandum and other Department of Justice position memorandums regarding marijuana

• Recognize the Federation of State Medical Boards’ (FSMB) “Model Guidelines for the Recommendation of Marijuana in Patient Care” as a policy document that is intended as a resource for state medical boards in regulating physicians and physician assistants

• Recognize the Federation of State Medical Boards’ “Model Guidelines for the Recommendation of Marijuana in Patient Care” as a resource for physicians

• Describe the National Academies of Science, Engineering and Medicine’s 2017 report, The Health Effects of Marijuana and Cannabinoids: The Current State of Evidence and Recommendations for Research

• Recognize the National Academies of Science, Engineering and Medicine’s 2017 report, The Health Effects of Marijuana and Cannabinoids: The Current State of Evidence and Recommendations for Research as a resource for clinical information on the effects of marijuana and  cannabinoid use

• Explain why the findings from studies examining recreational marijuana use may not be applicable to medical marijuana use

• Describe the FDA drug approval process

• Discuss the cannabinoid –based drugs approved by the FDA

• Discuss the indicated uses of the FDA-approved cannabinoid –based drugs

Term of Offering

This activity was released on 4/30/19 and is valid for one year. Requests for credit must be made no later than 4/30/20.

Global Contact Information

For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions for Obtaining Credit

In order to receive credit for this activity, the participant must complete the activity, pass the posttest with a score of 70% or greater, and fill out the activity evaluation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and The Answer Page do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Details

Credits: 1.5 CME/CE credits
Mobile-friendly: Yes